Senseonics Holdings, Inc.
NASDAQ:SENSMedical - Devices
-$0.09 today
- Market cap
- $487.82M
- Beta
- 0.97
- P/E (TTM)
- -3.5
- EPS (TTM)
- -$1.90
Volume 1.32M
Average 0.71M
Fair Value & DCF
Compare our fair value with your own assumptions
Intrinsic Alpha selects a valuation method suited to the business. Use the calculator below to build an independent scenario with your preferred cash-flow basis.
Senseonics Holdings, Inc.
NASDAQ:SENS
Intrinsic Alpha fair value
Locked
Current Price
$8.91
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Build your own valuation
Test an independent scenario and compare it with Intrinsic Alpha's estimate.
Sign in to use the DCF calculator
Free accounts get 5 valuations per week. Upgrade for more.
Growth Analysis
Historical CAGR & forward analyst estimates
| Metric | 10yr | 5yr | 3yr | Fwd Est. |
|---|---|---|---|---|
| EPS | N/A | N/A | N/A | N/A2 analysts |
| Revenue | N/A | N/A | +29.1% | +51.9% (5yr)3 analysts |
| Net Income | N/A | N/A | N/A | N/A3 analysts |
| EBIT | N/A | N/A | N/A | N/A3 analysts |
Analysis
Recent growth has been strongest in Revenue at +29.1% over three years. Forward estimates point to Revenue at +51.9% (5yr), giving you a quick check on whether expectations are accelerating or cooling.
Estimates & History
Historical data and analyst estimates. Solid bars are actuals; dashed-border bars are future estimates.
Competitor Valuations
Peer stocks ranked by intrinsic value status
| Company | Market Cap | Price | Valuation | P/E | 1Y Return |
|---|---|---|---|---|---|
DexCom, Inc. NASDAQ:DXCM | $31.08B | $83.33 | Overvalued | 29.9 | +37.26% |
Insulet Corporation NASDAQ:PODD | $10.58B | $152.48 | Overvalued | 33.2 | -56.14% |
MiniMed Group, Inc. Common Stock NASDAQ:MMED | $5.06B | $17.99 | Not rated | -14.2 | — |
Tandem Diabetes Care, Inc. NASDAQ:TNDM | $1.40B | $20.07 | Not rated | -11.3 | -13.85% |
Beta Bionics, Inc. NASDAQ:BBNX | $738.73M | $16.42 | Not rated | -9.1 | -53.10% |
Continue the stock analysis
Jump to another research area for this company.